Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Vertex Pharmaceuticals Incorporated    VRTX

Delayed Quote. Delayed  - 07/22 10:00:00 pm
93.89 USD   +0.73%
07/22 VERTEX PHARMACE : Moderna discuss mRNA Therapeutics in cystic fibros..
07/14 VERTEX PHARMACE : to Announce Second Quarter 2016 Financial Results ..
07/06 VERTEX PHARMACE : and Moderna to develop cystic fibrosis mRNA Therap..
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
07/18/2016 07/19/2016 07/20/2016 07/21/2016 07/22/2016 Date
89.42(c) 87.43(c) 91.15(c) 93.21(c) 93.89(c) Last
1 127 156 1 112 312 1 309 436 1 783 324 1 228 207 Volume
-0.88% -2.23% +4.25% +2.26% +0.73% Change
More quotes
Financials ($)
Sales 2016 1 779 M
EBIT 2016 249 M
Net income 2016 33,6 M
Finance 2016 414 M
Yield 2016 -
Sales 2017 2 507 M
EBIT 2017 809 M
Net income 2017 587 M
Finance 2017 1 437 M
Yield 2017 -
P/E ratio 2016 932,37
P/E ratio 2017 42,26
EV / Sales2016 12,8x
EV / Sales2017 8,69x
Capitalization 23 224 M
More Financials
Company
Vertex Pharmaceuticals, Inc. engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases in specialty markets.It focuses on development and commercializing therapies for the treatment of cystic fibrosis; infectious... 
More about the company
Surperformance© ratings of Vertex Pharmaceuticals Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on VERTEX PHARMACEUTICALS INC
07/22 VERTEX PHARMACEUTICALS : Moderna discuss mRNA Therapeutics in cystic fibrosis
07/21 VERTEX PHARMACEUTICALS : to Announce Second Quarter 2016 Financial Results on Ju..
07/14 VERTEX PHARMACEUTICALS : Researchers at Vertex Pharmaceuticals Target Influenza ..
07/14 VERTEX PHARMACEUTICALS : to Announce Second Quarter 2016 Financial Results on Ju..
07/06 VERTEX PHARMACEUTICALS : and Moderna to develop cystic fibrosis mRNA Therapeutic..
07/06 VERTEX PHARMACEUTICALS : and Moderna Establish Exclusive Collaboration to Discov..
07/01 VERTEX PHARMACEUTICALS : Exploring the need for mutation-specific treatments in ..
06/23 VERTEX PHARMACEUTICALS : Reports from Vertex Pharmaceuticals Describe Recent Adv..
06/18 VERTEX PHARMACEUTICALS INCORPORATED : (VRTX) Stock Rating Reaffirmed by Jefferie..
06/17 VERTEX PHARMACEUTICALS : Orkambi’s cost too high for benefit offered, says..
More news
Sector news : Bio Therapeutic Drugs
07/21DJAmgen and Allergan Study Finds Biosimilar Comparable to Herceptin
07/12DJAmgen Biosimilar Gets Thumbs-Up From FDA Panel
07/12DJJuno to Resume Clinical Trial of Anticancer Treatment
07/09DJCorrections & Amplifications -- WSJ
07/08DJAMGEN : Theranos Dealt Blow as Holmes Is Banned From -2-
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
07/15 Stocks Are Not Overvalued - Cramer's Mad Money (7/14/16)
07/07 Nivalis completes enrollment in mid-stage study of N91115 in cystic fibrosis
07/06 Biotechnology - The Perfect Yo-Yo
07/06 Vertex and Moderna team up to develop mRNA therapeutics for cystic fibrosis
07/04 FINDING VALUE WITH THE PIOTROSKI F-S : Part 3
Advertisement
Chart VERTEX PHARMACEUTICALS INC
Duration : Period :
Vertex Pharmaceuticals Inc Technical Analysis Chart | VRTX | US92532F1003 | 4-Traders
Full-screen chart
Technical analysis trends VERTEX PHARMACEUT...
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus 
Mean consensus OUTPERFORM
Number of Analysts 22
Average target price 109 $
Spread / Average Target 16%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Jeffrey M. Leiden Chairman, President & Chief Executive Officer
Simon Bedson SVP & GM-International Commercial Operations
Ian F. Smith CFO, EVP & Principal Financial Officer
Jeffrey A. Chodakewitz Chief Medical Officer & Executive Vice President
David Matthew Altshuler Chief Scientific Officer & EVP-Global Research
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
VERTEX PHARMACEUTICALS..-25.38%23 224
AMGEN, INC.2.06%124 454
GILEAD SCIENCES, INC.-14.47%115 269
CELGENE CORPORATION-10.22%83 285
REGENERON PHARMACEUTIC..-27.91%41 121
ACTELION LTD21.78%19 820
More Results